1. Home
  2. Live Updates
  3. இடைக்கால இணை தலை

இடைக்கால இணை தலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இடைக்கால இணை தலை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இடைக்கால இணை தலை Today - Breaking & Trending Today

Bi-Cultural Hebrew Academy Unveils the School's New Administrative Team

Bi-Cultural Hebrew Academy Unveils the School's New Administrative Team
jewishledger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishledger.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Tzvi Bernstein , David Pitkoff , Rachel Haron , Josh Rosenfeld , Board Of Trustees , School Principal David Giver , Lower School Principal , High School , Upper School Principal Rabbi Shimmy Trencher , School Principal Of Manhattan Day , Search Committee , Cultural Hebrew Academy Of Connecticut , Head Of School Jacqueline Herman , Head Of School , Rabbi Tzvi Bernstein , Bi Cultural Hebrew Academy , Interim Associate Head , Rabbi Josh Rosenfeld , Middle School Principal , Manhattan Day School , Lincoln Square Synagogue , Judaic Studies , School Jacqueline Herman , Rabbi Bernstein ,

Sunshine Biopharma and University of Georgia – SBFM-PL4 and Two Compounds


Sunshine Biopharma and University of Georgia – SBFM-PL4 and Two Compounds
February 9, 2021
Types: Inhibitors of coronavirus main protease (Mpro), an enzyme that is essential for viral replication.
2021 Status: Sunshine Bio said February 10 that it launched a transgenic mice study of its COVID-19 treatment that has been under development since May 2020. The mice being used in the study have been genetically engineered to express the human angiotensin-converting enzyme 2 (hACE2) transmembrane protein in their lungs making them susceptible to lethal infection by SARS-CoV-2. The SARSCoV-2 virus uses the hACE2 receptor to gain entry into human cells to replicate. Sunshine said the goal of the study is to determine if its protease inhibitors will protect the hACE2- transgenic mice from disease progression and death following infection with SARS-CoV-2. ....

Scottd Pegan , College Of Pharmacy , Biomedical Sciences , University Of Georgia , Sunshine Biopharma , Drug Discovery , Interim Associate Head , கல்லூரி ஆஃப் மருந்தகம் , உயிர் மருத்துவ அறிவியல் , பல்கலைக்கழகம் ஆஃப் ஜார்ஜியா , மருந்து கண்டுபிடிப்பு , இடைக்கால இணை தலை ,